These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9380912)

  • 61. Screening for hemochromatosis can prevent serious disease.
    Marino GG
    J Am Osteopath Assoc; 1999 May; 99(5):240-1. PubMed ID: 10370273
    [No Abstract]   [Full Text] [Related]  

  • 62. [Primary hemochromatosis--prevalence, pathogenesis and clinical findings].
    Björn-Rasmussen E; Rubio C
    Lakartidningen; 1984 Feb; 81(6):441-4. PubMed ID: 6700309
    [No Abstract]   [Full Text] [Related]  

  • 63. A public health perspective on vision screening.
    Myrowitz E
    Am J Optom Physiol Opt; 1984 Jun; 61(6):359-60. PubMed ID: 6742093
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Screenings, between clinical and public health].
    Guessous I; Paccaud F
    Rev Med Suisse; 2010 Jul; 6(256):1387-8. PubMed ID: 20701013
    [No Abstract]   [Full Text] [Related]  

  • 65. Issues in biomarker identification, validation and development for disease diagnostics in Public Health.
    Kempsell KE; Ball G; Szakmany T
    Expert Rev Mol Diagn; 2016; 16(4):383-6. PubMed ID: 26680111
    [No Abstract]   [Full Text] [Related]  

  • 66. Overlooked, tired and very angry.
    Stewart B
    Nurs Stand; 1996 Jan 17-23; 10(17):22-3. PubMed ID: 8602926
    [No Abstract]   [Full Text] [Related]  

  • 67. Estimating prevalence from the results of a screening test.
    Rogan WJ; Gladen B
    Am J Epidemiol; 1978 Jan; 107(1):71-6. PubMed ID: 623091
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Commentary: a radical future for public health.
    Weed DL
    Int J Epidemiol; 2001 Jun; 30(3):440-1. PubMed ID: 11416060
    [No Abstract]   [Full Text] [Related]  

  • 69. [Routine check-up in an asymptomatic population].
    Levy S; Bentwich Z
    Harefuah; 1984 Jun; 106(11):522-5. PubMed ID: 6479712
    [No Abstract]   [Full Text] [Related]  

  • 70. Minnesota surveillance for unexplained deaths and critical illnesses of possible infectious cause.
    Rainbow J; Lynfield R; Johnson JR; Danila RN
    Minn Med; 2000 Jan; 83(1):51-3. PubMed ID: 10680433
    [No Abstract]   [Full Text] [Related]  

  • 71. Community Screening for Diseases - A Useful Public Health Tool.
    Ahmad TM
    J Coll Physicians Surg Pak; 2019 May; 29(5):401-402. PubMed ID: 31036104
    [No Abstract]   [Full Text] [Related]  

  • 72. [Sensitivity and specificity].
    Andersen B
    Nord Med; 1969 Jul; 82(30):926-7. PubMed ID: 5808584
    [No Abstract]   [Full Text] [Related]  

  • 73. [Feasibility and economic issues should be considered for setting up of research projects for screening in population].
    Zhao YM
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):793. PubMed ID: 16255866
    [No Abstract]   [Full Text] [Related]  

  • 74. Hemochromatosis; review of literature and presentation of a case.
    SMITH HL; CZUJ JM
    J Mich State Med Soc; 1948 Feb; 47(2):177-82. PubMed ID: 18911189
    [No Abstract]   [Full Text] [Related]  

  • 75. Hemochromatosis; a review of the literature.
    DOANE JC; KRAVITZ CH; ROSENSTEIN G
    Pa Med J; 1950 Oct; 53(10):1081-4. PubMed ID: 14780812
    [No Abstract]   [Full Text] [Related]  

  • 76. Screening for hemochromatosis.
    Bacon BR
    Curr Gastroenterol Rep; 2006 Feb; 8(1):5-6. PubMed ID: 16510028
    [No Abstract]   [Full Text] [Related]  

  • 77. [Should we screen for hemochromatosis? Critical analysis of the literature].
    Charvet-Protat S; Yaouanq J; Fleurette F
    Rev Epidemiol Sante Publique; 1997 Sep; 45(4):315-27. PubMed ID: 9380912
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Genetic hemochromatosis: importance of population screening?].
    Cartabellotta A; Montalto G
    Recenti Prog Med; 1996 Mar; 87(3):118-23. PubMed ID: 8650432
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Screening for hemochromatosis: phenotype versus genotype.
    Edwards CQ; Griffen LM; Ajioka RS; Kushner JP
    Semin Hematol; 1998 Jan; 35(1):72-6. PubMed ID: 9460810
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms.
    Gagné G; Reinharz D; Laflamme N; Adams PC; Rousseau F
    Clin Genet; 2007 Jan; 71(1):46-58. PubMed ID: 17204047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.